Home Data Calendar Blog

QDEL

Tables

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Weighted Average Number Of Diluted Shares Outstanding 67.3067.1066.90NA66.9066.8067.10NA67.5052.9042.40NA42.5042.40
Weighted Average Number Of Shares Outstanding Basic 67.3067.1066.90NA66.9066.8066.60NA66.9052.2041.90NA41.7041.70
Earnings Per Share Basic -0.30-2.20-25.500.11-0.19-0.800.73-0.010.290.3711.466.835.170.46
Earnings Per Share Diluted -0.30-2.20-25.500.11-0.19-0.800.730.000.280.3611.316.715.080.45

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Revenue From Contract With Customer Including Assessed Tax 727.10637.00711.00742.60744.00665.10846.10866.50783.80613.401002.30636.90509.80176.60
Revenues 727.10637.00711.00742.60744.00665.10846.10866.50783.80613.401002.30636.90509.80176.60
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 374.80361.00378.90361.30375.90368.70397.50417.50376.30275.90260.30145.70134.4068.60
Research And Development Expense 55.9056.3059.2059.3062.4062.8062.3064.3065.6034.2026.4026.1023.7022.60
Selling General And Administrative Expense 186.40188.20204.70187.60194.10179.10202.40213.60204.20118.4084.8073.7063.0054.20
Operating Income Loss 15.00-117.50-1758.0040.1026.30-26.9099.6086.5056.8079.70620.70376.70281.8023.30
Interest Income Expense Net -42.90-41.00-39.00-36.70-37.70-36.50-36.70-34.70-29.70-10.30-1.00-1.10-1.30-1.40
Allocated Share Based Compensation Expense 12.5011.209.1015.7017.1017.0014.0015.1016.2015.907.406.707.005.80
Income Tax Expense Benefit -8.90-15.20-92.90-16.20-2.80-11.2011.2010.8012.1023.60140.7084.0065.802.60
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax -40.506.9024.60-42.6018.2035.70-22.60-13.109.105.400.100.100.400.60
Other Comprehensive Income Loss Net Of Tax 21.101.603.80NA-36.9043.008.30NA-83.80-60.90-0.20NA-0.200.90
Net Income Loss -19.90-147.70-1706.007.00-12.70-53.2048.8030.3019.2019.30479.90291.30215.7019.10
Comprehensive Income Net Of Tax 1.20-146.10-1702.2030.20-49.60-10.2057.10107.20-64.60-41.60479.80290.80215.6020.00
Goodwill Impairment Loss 0.000.001743.90NANANANANANANANANANANA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Assets 6801.106689.206703.308563.108539.108550.308787.108855.808655.508822.40NA2430.40NANA
Liabilities 3614.403515.703395.603557.203572.403547.803790.603921.203860.203902.80NA501.00NANA
Liabilities And Stockholders Equity 6801.106689.206703.308563.108539.108550.308787.108855.808655.508822.40NA2430.40NANA
Stockholders Equity 3186.703173.503307.705005.904966.705002.504996.504934.604795.304919.602414.901929.401634.001411.10

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Assets Current 1412.601341.301212.401310.501371.301308.101498.901575.101445.201559.10NA1440.30NANA
Cash And Cash Equivalents At Carrying Value 143.70107.0078.50118.90149.30178.60353.90292.90212.20379.00NA802.80NANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 144.00107.5079.00119.50149.90179.60354.90293.90213.20380.601275.50802.80578.40593.20
Accounts Receivable Net Current 294.90269.50271.70303.30331.20246.70274.80453.90416.60379.20NA378.00NANA
Inventory Net 577.00602.00583.10577.80551.70542.20528.60524.10536.20552.70NA198.80NANA
Other Assets Current 3.002.902.603.103.103.100.800.901.301.10NA4.50NANA
Prepaid Expense And Other Assets Current 344.20310.00279.10262.10295.20295.50298.80252.10228.40195.70NA35.00NANA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Amortization Of Intangible Assets 51.9051.9051.7051.2051.4051.4050.8053.9050.5021.007.106.906.906.80
Property Plant And Equipment Net 1363.901326.701441.301443.801369.401376.201361.701339.001261.601110.10NA349.20NANA
Goodwill 770.60732.50734.802492.002442.902470.902491.302476.802357.702589.60NA337.00NANA
Intangible Assets Net Excluding Goodwill 2795.902836.002887.302934.302976.503035.703078.503123.803223.903194.90NA98.70NANA
Other Assets Noncurrent 257.10250.80222.10179.60179.20141.20127.00122.70164.40152.10NA19.60NANA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Liabilities Current 1027.30932.40779.80833.80860.00790.00907.801007.00872.70900.00NA323.50NANA
Debt Current 373.80356.40161.10139.80193.00207.40207.50207.50207.60207.80NA0.30NANA
Long Term Debt Current 373.80356.40161.10139.80193.00207.40207.50207.50207.60207.80NA0.30NANA
Accounts Payable Current 247.20237.40249.60294.80253.00225.90241.50283.30241.80247.30NA101.50NANA
Other Accrued Liabilities Current 84.9084.7088.50115.70114.40NANA97.40NANANANANANA
Accrued Income Taxes Current 1.903.509.5011.101.802.1016.3051.6067.3069.10NA66.90NANA
Other Liabilities Current 291.40249.10250.70303.30305.40273.10334.00325.40240.50258.90NA114.40NANA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Debt And Capital Lease Obligations 2550.402563.602402.102414.602274.602308.502379.602430.802482.002533.30NA0.40NANA
Long Term Debt And Capital Lease Obligations 2176.602207.202241.002274.802467.602515.902587.102638.302689.602741.10NA0.70NANA
Deferred Income Tax Liabilities Net 117.20127.90125.60192.20196.50199.60208.80213.20256.40214.00NANANANA
Other Liabilities Noncurrent 119.3070.5067.4083.6065.4068.50111.1083.8086.6087.30NA48.50NANA
Operating Lease Liability Noncurrent 174.00177.70181.80172.80175.90181.20183.30186.40162.50168.20NA128.60NANA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Stockholders Equity 3186.703173.503307.705005.904966.705002.504996.504934.604795.304919.602414.901929.401634.001411.10
Stockholders Equity Including Portion Attributable To Noncontrolling Interest -3.50-24.60-26.20-30.00-53.20-16.30-59.30-67.60-144.50-60.700.200.40NANA
Additional Paid In Capital 2875.902863.902852.002848.002839.002825.202809.002804.302772.202831.90NA279.80NANA
Retained Earnings Accumulated Deficit 314.20334.10481.802187.802180.802193.502246.702197.902167.602148.40NA1649.20NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -3.50-24.60-26.20-30.00-53.20-16.30-59.30-67.60-144.50-60.70NA0.40NANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 12.0010.309.00NA13.5013.7010.40NA12.6014.706.20NA5.605.80

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Net Cash Provided By Used In Operating Activities 117.90-97.90-0.7080.4041.50-30.60188.90169.40-9.70224.70500.90321.4077.00NA
Net Cash Provided By Used In Investing Activities -56.50-35.30-20.20-55.10-21.30-42.30-68.90-59.30-29.80-1530.40-24.70-96.00-93.20NA
Net Cash Provided By Used In Financing Activities -26.30162.50-18.50-57.80-48.70-99.70-59.60-31.70-126.00413.10-3.40-0.901.80NA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Net Cash Provided By Used In Operating Activities 117.90-97.90-0.7080.4041.50-30.60188.90169.40-9.70224.70500.90321.4077.00NA
Net Income Loss -19.90-147.70-1706.007.00-12.70-53.2048.8030.3019.2019.30479.90291.30215.7019.10
Depreciation Depletion And Amortization 113.10116.10114.90115.40113.10114.50114.20116.60104.2047.5015.3015.4012.7012.30
Increase Decrease In Accounts Receivable 16.602.20-26.40-35.9090.40-27.30-187.2031.4050.70-423.80191.5042.60289.70NA
Increase Decrease In Inventories 15.7057.5037.7065.6060.0048.7037.3019.0061.8053.40-17.301.70-21.50NA
Increase Decrease In Accounts Payable 7.00-13.20-10.709.3028.70-13.60-21.4014.3056.00-99.4052.6013.906.60NA
Share Based Compensation 12.3011.209.0012.3014.1014.2011.0011.8013.3015.907.406.707.00NA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Net Cash Provided By Used In Investing Activities -56.50-35.30-20.20-55.10-21.30-42.30-68.90-59.30-29.80-1530.40-24.70-96.00-93.20NA
Payments To Acquire Property Plant And Equipment 46.5035.3066.1048.6043.4051.3066.0061.7030.5026.2022.5032.40106.90NA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Net Cash Provided By Used In Financing Activities -26.30162.50-18.50-57.80-48.70-99.70-59.60-31.70-126.00413.10-3.40-0.901.80NA

    2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 2021-07-04
Revenues 727.10637.00711.00742.60744.00665.10846.10866.50783.80613.401002.30636.90509.80176.60
Donor Screening 28.00NANANA35.00NANANANANANANANANA
Immunohematology 132.00NANANA128.90NANANANANANANANANA
Labs 355.90354.20356.90351.90341.40361.40370.70314.70334.80157.4013.3012.1011.4010.40
Molecular Diagnostics 5.604.407.208.505.606.2011.4014.6015.4020.7046.0050.9054.8034.40
Point Of Care 205.60117.10186.60216.80233.10134.20308.10374.70270.50367.10943.00573.90443.60131.80
China 80.4081.6076.1077.1081.1081.3070.6056.9080.8073.60NA11.2012.1017.80
EMEA 84.0081.1084.8090.9074.5080.6081.3075.8073.7042.10NA15.8014.8017.90
North America 436.20350.10433.90450.30465.20378.80582.80619.20517.60438.20NA598.00466.80122.00
Other 126.50124.20116.20124.30123.20124.40111.40114.60111.7059.50NA11.9016.1018.90
Revenue From Contract With Customer Including Assessed Tax 727.10637.00711.00742.60744.00665.10846.10866.50783.80613.401002.30636.90509.80176.60
Collaborative Arrangement Transaction With Party To Collaborative Arrangement 2.002.403.101.401.600.6022.402.802.702.00NANANANA

Plots across concepts


IncomeStatement
Income Loss From Continuing Operations 
Before Income Taxes Extraordinary Items Noncontrolling Interest
Expenses
Income Tax Expense Benefit
Balance Sheet
Cash And Cash Equivalents At Carrying Value
Assets
Derivative Assets
Current Assets
Other Assets Current
NonCurrent Assets
Deferred Income Tax Assets Net
Liabilities
Derivative Liabilities
Current Liabilities
Accrued Income Taxes Current
Noncurrent Liabilities
Deferred Income Tax Liabilities Net
Stockholders Equity
Accumulated Other Comprehensive Income Loss Net Of Tax
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Common Stock Shares Issued
OperatingLeaseLiability
Operating Lease Liability Current
InventoryNet
Inventory Work In Process Net Of Reserves
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept